Cargando…
Performance of dRAST on Prospective Clinical Blood Culture Samples in a Simulated Clinical Setting and on Multidrug-Resistant Bacteria
There is an utmost need for rapid antimicrobial susceptibility testing (AST) of bacteria causing bloodstream infections (BSI). The dRAST (QuantaMatrix Inc., Seoul) is a commercial method that can be performed directly from positive blood cultures. The present study aims to evaluate the performance o...
Autores principales: | Wong, Alicia Y. W., Johnsson, Alexander T. A., Özenci, Volkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941874/ https://www.ncbi.nlm.nih.gov/pubmed/35234503 http://dx.doi.org/10.1128/spectrum.02107-21 |
Ejemplares similares
-
Performance Evaluation of the Quantamatrix QMAC-dRAST System for Rapid Antibiotic Susceptibility Testing Directly from Blood Cultures
por: Rosselin, Manon, et al.
Publicado: (2022) -
Antimicrobial Resistance Prediction in PATRIC and RAST
por: Davis, James J., et al.
Publicado: (2016) -
Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system
por: Ullberg, Måns, et al.
Publicado: (2019) -
The MG-RAST metagenomics database and portal in 2015
por: Wilke, Andreas, et al.
Publicado: (2016) -
Evaluation of Four Lateral Flow Assays for the Detection of Legionella Urinary Antigen
por: Wong, Alicia Y. W., et al.
Publicado: (2021)